Michael Johnson
Medical · Conyers, GANPI 1336538974
Payments from drug & device makers
Across 157 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$439
- Lilly USA, LLC$355
- Otsuka America Pharmaceutical, Inc.$286
- Novo Nordisk$277
- Johnson & Johnson$211
- Pfizer$174
- plus $922 from 17 others
What the payments were for
- Food & beverage$2,664100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 26 | $439 |
| Lilly USA, LLC | 18 | $355 |
| Otsuka America Pharmaceutical, Inc. | 14 | $286 |
| Novo Nordisk | 17 | $277 |
| Johnson & Johnson | 22 | $211 |
| Pfizer | 8 | $174 |
| Boehringer Ingelheim | 7 | $125 |
| Astellas Pharma US Inc | 5 | $119 |
| Exact Sciences | 6 | $103 |
| Bayer | 5 | $99 |
| Abbott | 4 | $67 |
| Merck | 4 | $63 |
| GSK | 3 | $57 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $50 |
| Sanofi Pasteur Inc. | 3 | $46 |
| Amgen | 3 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| AbbVie | 1 | $17 |
| Novartis | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$2,664 in reported general payments places this provider in the 70th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $70,261 |
| JanuviaSitagliptin Phosphate | 12 | $16,345 |
| JardianceEmpagliflozin | 14 | $15,042 |
| PaxlovidNirmatrelvir/Ritonavir | 32 | $2,795 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 63 | $1,396 |
| Atorvastatin Calcium | 172 | $1,199 |
| Losartan Potassium | 102 | $1,067 |
| Fluticasone Propionate | 59 | $966 |
| Amlodipine Besylate | 202 | $903 |
| Gabapentin | 57 | $868 |
| Famotidine | 68 | $864 |
| Lisinopril | 160 | $768 |
| Tamsulosin Hcl | 80 | $712 |
| Levothyroxine Sodium | 82 | $636 |
| Metoprolol Succinate | 49 | $581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $277 | $70,26137 claims |
| MerckJanuvia | $63 | $16,34512 claims |
| Boehringer IngelheimJardiance | $125 | $15,04214 claims |
| PfizerPaxlovid | $174 | $2,79532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 950 medical providers in Georgia.
Other medical in Conyers
- Katherine SimmonConyers$12K
- Ryan HoodConyers$11K
- Kaitlyn SmithConyers$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.